The HTI Valori Mobiliare brokerage firm based in Bucharest remained the number one player in the RASDAQ brokers” ranking, due to transactions handled on behalf of US businessman Robert Ferran. Ferran kept selling his shares in Bucharest-based drug maker Biofarm in March.
HTI achieved a traded volume of 8.9 million euros in March, which accounts for 21% of the market. Ferran last month reduced his stake in Biofarm to 5% from more than 49% at the beginning of the year. The three-month ranking shows HTI Valori Mobiliare in the lead again, with 23.2 million euros in transactions and 14.3% market share.
Ferran was not the only owner that decided to sell his Biofarm interest, as International Pharmaceutical Group and Health Sciences Group, two of the principal shareholders of the pharmaceutical company until recently reduced their stakes in it, as well. Biofarm was the most traded company last month, with transactions worth more than 8.1 million euros.
The transactions handled by Alpha Finance for the investment funds managed by the Estonians at Trigon Capital helped this firm up in the RASDAQ brokers” ranking in March to the second place, due to 3.3 million euros in traded volume and 8% market share. Trigon Second Wave Fund, managed by Trigon Capital was reported as owning 5.7% in harbour operator Socep Constanta. Socep was among the most traded companies last month, with operations involving its shares amounting to 3 million euros.
Alpha Finance brokered 9.5 million euros” worth in the first quarter, ranking fifth with 5.8% market share.
catalin.ciocan@zf.ro